These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10030501)

  • 41. Post-Lyme disease syndrome under trial.
    O'Brien C
    Mol Med Today; 1996 Oct; 2(10):407. PubMed ID: 8897433
    [No Abstract]   [Full Text] [Related]  

  • 42. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective immunity elicited by rBCG vaccines.
    Stover CK; Bansal GP; Langerman S; Hanson MS
    Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi.
    Langermann S; Palaszynski S; Sadziene A; Stover CK; Koenig S
    Nature; 1994 Dec; 372(6506):552-5. PubMed ID: 7990928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of lymphocyte proliferative responses by a canine Lyme disease vaccine of recombinant outer surface protein A (OspA).
    Chiao JW; Villalon P; Schwartz I; Wormser GP
    FEMS Immunol Med Microbiol; 2000 Jul; 28(3):193-6. PubMed ID: 10865170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
    Comstedt P; Schüler W; Meinke A; Lundberg U
    PLoS One; 2017; 12(9):e0184357. PubMed ID: 28863166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R
    Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lyme disease: uphill struggle.
    Abbott A
    Nature; 2006 Feb; 439(7076):524-5. PubMed ID: 16452949
    [No Abstract]   [Full Text] [Related]  

  • 49. Lyme borreliosis: A neglected zoonosis in Egypt.
    Elhelw RA; El-Enbaawy MI; Samir A
    Acta Trop; 2014 Dec; 140():188-92. PubMed ID: 25239124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
    J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.
    Simon MM; Schaible UE; Wallich R; Kramer MD
    Immunol Today; 1991 Jan; 12(1):11-6. PubMed ID: 2015043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of lipidation of recombinant Lyme vaccine protein (rOspA) by electrospray mass spectroscopy.
    Wu XD; Marakov KL; Martinez PA; McVerry PH; Malinzak DA
    J Pharm Biomed Anal; 1997 Dec; 16(4):613-7. PubMed ID: 9502157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current status of vaccine development of Lyme borreliosis].
    Masuzawa T
    Nihon Saikingaku Zasshi; 1993 Mar; 48(2):389-97. PubMed ID: 8315805
    [No Abstract]   [Full Text] [Related]  

  • 54. Study highlights variation in Lyme disease presentation.
    Quirk M
    Lancet Infect Dis; 2002 May; 2(5):266. PubMed ID: 12062987
    [No Abstract]   [Full Text] [Related]  

  • 55. Pediatricians alerted to five new vaccines.
    Jefferson T
    JAMA; 1999 Jun; 281(21):1973-5. PubMed ID: 10359368
    [No Abstract]   [Full Text] [Related]  

  • 56. Spirochetes: vaccines, animal models and diagnostics.
    Simon M; Milward F; Lefebvre R; Schouls L; Fikrig E; Wasmoen T; Stover K; Menefee B; Robinson J
    Res Microbiol; 1992; 143(6):641-7. PubMed ID: 1475524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biting back at Lyme disease.
    Travis J
    Science; 1992 Jun; 256(5064):1623. PubMed ID: 1609273
    [No Abstract]   [Full Text] [Related]  

  • 58. Disarming Lyme disease.
    Kantor FS
    Sci Am; 1994 Sep; 271(3):34-9. PubMed ID: 8091189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of an experimental glycolipoprotein vaccine against Lyme disease.
    Pozsgay V; Kubler-Kielb J
    Carbohydr Res; 2007 Feb; 342(3-4):621-6. PubMed ID: 17182019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lyme disease vaccine: good for dogs, adults, and children?
    Feder HM
    Pediatrics; 2000 Jun; 105(6):1333-4. PubMed ID: 10835077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.